| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |